Technical Analysis for DSGN - Design Therapeutics, Inc.

Grade Last Price % Change Price Change
D 2.52 -2.33% -0.06
DSGN closed down 2.33 percent on Monday, March 18, 2024, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: Mar 19
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Gapped Up Strength 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Crossed Above 50 DMA Bullish -2.33%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.33%
Pocket Pivot Bullish Swing Setup -2.33%
Inside Day Range Contraction -2.33%
Lower Bollinger Band Touch Weakness -2.33%
Oversold Stochastic Weakness -2.33%

   Recent Intraday Alerts

Alert Time
Lower Bollinger Band Support about 12 hours ago
Down 5% about 13 hours ago
Fell Below Previous Day's Low about 13 hours ago
Gap Up Closed about 13 hours ago
Gap Up Partially Closed about 13 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. The company was incorporated in 2017 and is based in Carlsbad, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Rare Diseases Medical Genetics Neurological Disorders Stroke Degenerative Disease Myotonic Dystrophy Ataxia Fragile X Syndrome Friedreich's Ataxia Trinucleotide Repeat Disorders

Is DSGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.47
52 Week Low 1.94
Average Volume 198,275
200-Day Moving Average 3.46
50-Day Moving Average 2.55
20-Day Moving Average 2.77
10-Day Moving Average 2.73
Average True Range 0.15
RSI (14) 43.18
ADX 28.82
+DI 12.34
-DI 21.30
Chandelier Exit (Long, 3 ATRs) 2.53
Chandelier Exit (Short, 3 ATRs) 2.78
Upper Bollinger Bands 3.03
Lower Bollinger Band 2.51
Percent B (%b) 0.03
BandWidth 18.93
MACD Line 0.01
MACD Signal Line 0.06
MACD Histogram -0.0507
Fundamentals Value
Market Cap 141.13 Million
Num Shares 56 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -1.95
Price-to-Sales 22642.01
Price-to-Book 0.45
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.79
Resistance 3 (R3) 2.80 2.71 2.74
Resistance 2 (R2) 2.71 2.64 2.71 2.73
Resistance 1 (R1) 2.62 2.60 2.58 2.61 2.71
Pivot Point 2.53 2.53 2.51 2.53 2.53
Support 1 (S1) 2.44 2.46 2.40 2.43 2.33
Support 2 (S2) 2.35 2.42 2.35 2.31
Support 3 (S3) 2.26 2.35 2.30
Support 4 (S4) 2.25